日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Companies

Xi'an Janssen plans 10 drug launches in four areas by 2020

By Wang Wen (China Daily) Updated: 2015-10-31 09:50

Xi'an Janssen Pharmaceutical Ltd, Johnson & Johnson Services Inc's largest subsidiary in China, plans to launch more than 10 new medicines in China by 2020.

Kris Sterkens, chairman of Jassen Asia Pacific, said innovation remains its core strategy, and its products will be spread over four main treatment areas: tumors, the autoimmune system, mental health and infectious and metabolic diseases such as hepatitis and diabetes.

The firm's new-product strategy, he said, was being supported by a number of recent findings that showed China has strong demand for medicine targeted at those diseases.

A survey by the Economist Intelligence Unit, a global business intelligence belonging to the Economist Group, for instance, analyzed markets in five countries across Asia Pacific including China, and reached the conclusion that "the region now carries a huge global burden of non-communicable diseases, such as cancer and mental illness".

As many as 85 percent of deaths in China in 2010 were the result of non-communicable diseases, according to the report, with cancer, cardiovascular disease and diabetes topping the list of causes.

"Healthcare systems in Asia Pacific are struggling to manage the rise in non-communicable diseases and the shift to long-term treatment of chronic conditions," said Charles Ross, the survey report's editor.

Following on from those and other findings, Xi'an Janssen will launch a new product for prostate cancer soon, said Sterkens. Research is also being conducted on a diabetes medicine.

Xi'an Janssen has launched 14 major new products in the past five years aimed at treating conditions like human immunodeficiency virus, cancer and mental illness.

Established 30 years ago, it has been a regular investor in China since its launch.

A new $290 million plant in Xi'an will be in operation from 2018, said Cesar Rodriguez, the company's chief.

The new site will have an annual capacity of 280 million medicine packages, which will be sold around the world, said Rodriguez.

Xi'an Janssen is well known in China for over-the-counter drugs such as Domperidone and Daktarin.

Johnson & Johnson combined its OTC business in China last year with Xi'an Janssen, a controversial move at the time with some industry commentators fearing the integration might hurt sales.

Rodriguez insisted the integration, named One China OTC, has achieved strong results, although he refused to detail exact numbers.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 日韩av片在线免费观看 | 国产精品免费一区二区 | 国产理论片在线观看 | 成人字幕 | 久久不卡av| 在线h网站 | 国产小视频在线免费观看 | 生活一级片| 四虎永久免费观看 | 日本中文字幕免费在线观看 | 午夜丁香婷婷 | 亚洲一区视频在线 | 精品国产一区二区三区久久久蜜臀 | 午夜琪琪| 亚洲深夜视频 | 午夜视频在线观看免费视频 | 在线观看毛片视频 | 欧美日韩精品在线视频 | 人人澡人人射 | 91精品一区二区三区四区 | av中文字幕一区 | 91精品国产综合久久精品图片 | www.4hu95.com四虎 国产网站免费看 | 一级午夜 | 女同一区二区三区 | 亚洲精品aⅴ中文字幕乱码 亚洲精品视频在线 | 欧美毛片网站 | av有码在线 | 黄色欧美网站 | 黄色免费在线观看 | 久久99热这里只有精品 | www天天干| 天天操天天干天天干 | 狠狠操综合 | 激情婷婷色 | 午夜免费网址 | 中文字幕在线看 | 91少妇| 国产一二区在线观看 | 成人免费黄色小视频 | 亚洲精品9 |